HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Insel Selected Research

adenosine 5'-O-(3-thiotriphosphate)

3/2007Nerve growth factor-stimulated neuronal differentiation induces changes in P2 receptor expression and nucleotide-stimulated catecholamine release.
4/2006Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Insel Research Topics

Disease

12Neoplasms (Cancer)
01/2021 - 07/2003
7COVID-19
01/2021 - 01/2020
7Lymphoma (Lymphomas)
10/2015 - 05/2004
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 12/2008
4Pulmonary Hypertension
01/2020 - 01/2007
4Hypoxia (Hypoxemia)
01/2020 - 04/2006
4Heart Failure
01/2019 - 11/2007
4Hypertension (High Blood Pressure)
12/2008 - 08/2004
4Ischemia
03/2008 - 04/2003
4Cystic Fibrosis (Mucoviscidosis)
06/2007 - 07/2002
3Inflammation (Inflammations)
01/2021 - 01/2020
3Myocardial Infarction
11/2020 - 11/2007
3Colonic Neoplasms (Colon Cancer)
01/2018 - 06/2004
3Fibrosis (Cirrhosis)
05/2014 - 05/2012
3Reperfusion Injury
11/2008 - 05/2007
3Infarction (Infarctions)
01/2008 - 04/2003
2Lung Injury
10/2021 - 05/2004
2Asthma (Bronchial Asthma)
01/2020 - 02/2015
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2019 - 05/2004
2Pain (Aches)
01/2019 - 01/2018
2Adenocarcinoma
01/2018 - 07/2003
2Familial Primary Pulmonary Hypertension
09/2007 - 01/2007
2Pheochromocytoma
03/2007 - 04/2006
1Obstructive Lung Diseases (Obstructive Lung Disease)
10/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Thrombosis (Thrombus)
01/2021
1Infections
01/2021
1Thromboinflammation
01/2021
1Chemical and Drug Induced Liver Injury
01/2021
1Peripheral Arterial Disease
11/2020
1Pulmonary Arterial Hypertension
01/2020
1Acidosis
01/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Nervous System Diseases (Neurological Disorders)
01/2020
1Neuralgia (Stump Neuralgia)
01/2020
1Epilepsy (Aura)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Parkinson Disease (Parkinson's Disease)
01/2019

Drug/Important Bio-Agent (IBA)

8Cyclic AMP (AMP, Cyclic)IBA
01/2020 - 07/2002
7Pharmaceutical PreparationsIBA
01/2020 - 12/2005
5Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
10/2015 - 05/2004
5Cyclic NucleotidesIBA
09/2011 - 01/2007
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2020
4AngiotensinsIBA
01/2021 - 11/2020
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020 - 01/2018
4Messenger RNA (mRNA)IBA
11/2019 - 09/2011
4Purinergic P2Y2 ReceptorsIBA
12/2008 - 03/2006
3Angiotensin IIIBA
11/2020 - 05/2012
3Protons (Proton)IBA
01/2020 - 01/2018
3NucleotidesIBA
05/2014 - 04/2006
3CaveolinsIBA
11/2012 - 11/2008
3Adenosine (Adenocard)FDA LinkGeneric
09/2012 - 05/2005
3CollagenIBA
05/2012 - 05/2004
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
09/2011 - 12/2008
3Caveolin 1IBA
03/2008 - 05/2007
3Adenosine Triphosphate (ATP)IBA
03/2007 - 03/2006
2Adrenergic Receptors (Adrenergic Receptor)IBA
10/2021 - 07/2002
2ThrombinFDA Link
01/2021 - 11/2012
2LipidsIBA
01/2021 - 09/2006
2Angiotensin Receptor AntagonistsIBA
11/2020 - 01/2020
2EnzymesIBA
11/2020 - 07/2003
2Ion Channels (Ion Channel)IBA
01/2020 - 04/2006
2RNA (Ribonucleic Acid)IBA
01/2020 - 10/2019
2Biomarkers (Surrogate Marker)IBA
11/2019 - 01/2018
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 04/2008
2GlucocorticoidsIBA
10/2015 - 05/2004
2erythromycin propionate-N-acetylcysteinateIBA
10/2014 - 05/2012
2Caveolin 3IBA
05/2011 - 01/2008
2Protein Isoforms (Isoforms)IBA
12/2008 - 01/2007
2CholesterolIBA
05/2008 - 07/2006
2methyl-beta-cyclodextrinIBA
01/2008 - 07/2006
2IsofluraneFDA LinkGeneric
01/2008 - 05/2007
2Anesthetics (Anesthetic Agents)IBA
01/2008 - 05/2007
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2007 - 05/2007
2adenosine 5'-O-(3-thiotriphosphate)IBA
03/2007 - 04/2006
2Uridine Triphosphate (UTP)IBA
04/2006 - 03/2006
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
10/2021
1Cholinergic Antagonists (Anticholinergics)IBA
10/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1Cholinergic Agents (Cholinergics)IBA
10/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Ramipril (Altace)FDA LinkGeneric
01/2021
1ArsenicIBA
01/2021
1Therapeutic UsesIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2021
1Purinergic Receptors (Receptors, Purine)IBA
01/2021
1MethyltransferasesIBA
01/2021
1PoisonsIBA
01/2021
1arseniteIBA
01/2021
1ReninIBA
11/2020
1PAR-1 ReceptorIBA
11/2020
1Peptides (Polypeptides)IBA
11/2020
1Proteinase-Activated ReceptorsIBA
11/2020
1vorapaxarIBA
11/2020
1Surface Antigens (Surface Antigen)IBA
11/2019
1Dinoprostone (PGE2)FDA Link
01/2019

Therapy/Procedure

10Therapeutics
01/2021 - 05/2004
1Mechanical Ventilators (Ventilator)
01/2021